Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity

Neuroendocrinology Letters

Volumn 32, Issue 3, 2011, Pages 264-273

  Maes, Michael ^a   Galecki, Piotr ^b   Verkerk, Robert ^c   Rief, Winfried ^d,e  

^a Piyavate Hospital   (Thailand)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d Center for Behavioral Medicine   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Chronic fatigue; Cytokines; Inflammation; Oxidative stress; Serotonin; Tryptophan

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; KYNURENIC ACID; KYNURENINE AMINOTRANSFERASE; TRYPTOPHAN; TRYPTOPHAN CATABOLITE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PSYCHOLOGIC TEST; SCREENING FOR SOMATOFORM SYMPTOM; SOMATIC SYMPTOM INDEX; SOMATIZATION; SYMPTOM CHECKLIST 90;

EID: 80051959787     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Beck AT, Ward CH, Medelson M, Mock F, Erbaugh F (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
2. Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M (2002) Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22(1): 86-90. (Pubitemid 34101297)
3. Booij L, Swenne CA, Brosschot JF, Haffmans PM, Thayer JF, Van der Does AJ (2006) Tryptophan depletion affects heart rate variability and impulsivity in remitted depressed patients with a history of suicidal ideation. Biol Psychiatry 60(5): 507-514. (Pubitemid 44292162)
4. Brandacher G, Winkler C, Schroecksnadel K, Margreiter R, Fuchs D (2006) Antitumoral activity of interferon-gamma involved in impaired immune function in cancer patients. Curr Drug Metab 7(6): 599-612. (Pubitemid 44226588)
5. Brkic S, Tomic S, Marie D, Novakov Mikic A, Turkulov V (2010). Lipid peroxidation is elevated in female patients with chronic fatigue syndrome. Med Sci Monit. 16(12): CR628-32.
6. Brown FW, Golding JM, Smith GR Jr (1990) Psychiatric comorbidity in primary care somatization disorder. Psychosom Med 52(4): 445-451. (Pubitemid 20234859)
7. Burdette SD, Parilo, MA, Kaplan LJ, Bailey H (2010) Systemic Inflammatory Response Syndrome. http://emedicine.medscape.com/article/168943-overview. Medscape, eMedicine.
8. Cairns BE, Svensson P, Wang K, Hupfeld S, Graven-Nielsen T, Sessle BJ, Berde CB, Arendt-Nielsen L (2003) Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol 90(4): 2098-2105. (Pubitemid 37266480)
9. Cowen PJ, Parry-Billings M, Newsholme EA (1989) Decreased plasma tryptophan levels in major depression. J Affect Disord 16(1): 27-31. (Pubitemid 19020852)
10. Curzon G (1979) Study of disturbed tryptophan metabolism in depressive illness. Ann Biol Clin (Paris) 37(1): 27-33.
11. Curzon G, Sarna GS (1984) Tryptophan transport to the brain: newer findings and older ones reconsidered. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H, editors. Progress in Tryptophan and Serotonin Research. Berlin: Walter De Gruyter, pp 145-157.
12. Davies SJ, Hood SD, Argyropoulos SV, Morris K, Bell C, Witchel HJ, Jackson PR, Nutt DJ, Potokar JP (2006) Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders. J Clin Psychopharmacol 26(4): 414-418. (Pubitemid 44187646)
13. DeMyer MK, Shea PA, Hendrie HC, Yoshimura NN (1981) Plasma tryptophan and five other amino acids in depressed and normal subjects. Arch Gen Psychiatry 38(6): 642-646. (Pubitemid 11064820)
14. Derogatis LR (1994) Symptom Checklist-90-R. Administration, Scoring, and Procedures Manual, ed 3. Minneapolis: National Computer Systems.
15. Drummond PD (2006) Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia 26(10): 1225-1233.
16. Escobar JI, Burnam MA, Karno M, Forsythe A, Golding JM (1987) Somatization in the community. Arch Gen Psychiatry 44(8): 713-718. (Pubitemid 17138954)
17. Escobar JI, Rubio-Stipec M, Canino G, Karno M (1989) Somatic symptoms index (SSI): A new and abridged somatization construct - Prevalence and epidemiological correlates in two large community samples. J Nerv Ment Dis 177: 140-146. (Pubitemid 19091913)
18. Fernstrom JD (1984) Tryptophan availability and serotonin synthesis in rat brain: effects of experimental diabetes. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H, editors. Progress in Tryptophan and Serotonin Research. Berlin: Walter de Gruyter, pp 161-172.
19. Gabbay V, Klein RG, Katz Y, Mendoza S, Guttman LE, Alonso CM, Babb JS, Hirsch GS, Liebes L (2010) The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry Apr 12.
20. Harvey JA, Schlosberg AJ, Yunger LM (1975) Behavioral correlates of serotonin depletion. Fed Proc 34(9): 1796-1801.
21. Hervé C, Beyne P, Jamault H, Delacoux E (1996) Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B Biomed Appl 675(1): 157-161. (Pubitemid 26036980)
22. Hiller W, Zaudig M, Mombour W (1997) International Diagnostic Check Lists for ICD-10 and DSM-IV. Bern: Huber.
23. Huengsberg M, Winer J, Round R, Gompels M, Shahmanesh M (1998) Elevated serum kynurenine level is associated with peripheral neuropathy in HIV. Neuroscience of HIV Infection. J Neurovirol 4: 353.
24. Joseph MS, Brewerton TD, Reus VI, Stebbins GT (1984) Plasma L-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression. Psychiatry Res 11(3): 185-192. (Pubitemid 14128831)
25. Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K, Nakamura T (2009) Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2(1): 8.
26. Kaszaki J, Palásthy Z, Erczes D, Rácz A, Torday C, Varga G, Vécsei L, Boras M (2008) Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs. Neurogastroenterol Motil 20(1): 53-62. (Pubitemid 350277448)
27. Kékesi G, Horváth G (2002) Analgesic effect of kynurenic acid. Ideggyogy Sz 55(9-10): 313-322.
28. Kilkens TO, Honig A, van Nieuwenhoven MA, Riedel WJ, Brummer RJ (2004) Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls. Gut 53(12): 1794-1800. (Pubitemid 39556899)
29. Kroenke K, Spitzer RL, deGruy FV 3rd, Hahn SR, Linzer M, Williams JB, Brady D, Davies M (1997) Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 54(4): 352-358.
30. Ladwig KH, Marten-Mittag B, Erazo N, Gündel H (2001) Identifying somatization disorder in a population-based health examination survey: psychosocial burden and gender differences. Psychosomatics 42(6): 511-518. (Pubitemid 34084253)
31. Lehmann J (1972) Mental and neuromuscular symptoms in tryptophan deficiency: a review with special reference to mental symptoms in a selected material of carcinoid patients. Acta Psychiatr Scand (Suppl) 237.
32. Li J, McRoberts JA, Ennes HS, Trevisani M, Nicoletti P, Mittal Y, Mayer EA (2006) Experimental colitis modulates the functional properties of NMDA receptors in dorsal root ganglia neurons. Am J Physiol Gastrointest Liver Physiol 291(2): G219-228.
33. Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatr 19(1): 11-38.
34. Maes M (2010) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry [Epub ahead of print] PubMed PMID: 20599581.
35. Maes M, Meltzer HY (1995) The Serotonin Hypothesis of major depression. Selected Chapters on Mood Disorders. In: F.Bloom, D.Kupfer, editors. Psychopharmacology, The Fourth Generation of Progress. New York: Raven Press, pp 933-944.
36. Maes M, Twisk FN (2010). Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Med. 8: 35. Review.
37. Maes MH, De Ruyter M, Suy E (1987a) Prediction of subtype and severity of depression by means of dexamethasone suppression test, L-tryptophan: competing amino acid ratio, and MHPG flow. Biol Psychiatry 22(2): 177-188.
38. Maes M, De Ruyter M, Suy E (1987b) The renal excretion of xanthurenic acid following L-tryptophan loading in depressed patients. Human Psychopharmacol Clin Exp 2(4): 231-235.
39. Maes M, Jacobs MP, Suy E, Vandewoude M, Minner B, Raus J (1990a) Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients. Biol Psychiatry 27(8): 854-862. (Pubitemid 20145672)
40. Maes M, Maes L, Suy E (1990b) Symptom profiles of biological markers in depression: a multivariate study. Psychoneuroendocrinology 15(1): 29-37. (Pubitemid 20173718)
41. Maes M, Schotte C, Scharpé S, Martin M, Blockx P (1990c) The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients. J Affect Disord 18(2): 121-127. (Pubitemid 20038070)
42. Maes M, Minner B, Suy E (1991a). The relationships between the availability ofL-tryptophan to the brain, the spontaneous HPA-axis activity, and the HPA-axis responses to dexamethasone in depressed patients. J AminoAcids 1(1): 57-65
43. Maes M, Vandewoude M, Scharpé S, De Clercq L, Stevens W, Lepoutre L, Schotte C (1991b) Anthropometric and biochemical assessment of the nutritional state in depression: evidence for lower visceral protein plasma levels in depression. J Affect Disord 23(1): 25-33.
44. Maes M, Meltzer HY, Scharpé S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns P (1993) Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res 49(2): 151-165.
45. Maes M, Scharpé S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche BV, Cosyns P (1994) Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res 54(2): 143-160.
46. Maes M, Wauters A, Verkerk R, Demedts P, Neels H, Van Gastel A, Cosyns P, Scharpé S, Desnyder R (1996) Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacology 15(3): 243-251. (Pubitemid 26285654)
47. Maes M, Verkerk R, Vandoolaeghe E, Van Hunsel F, Neels H, Wauters A, Demedts P, Scharpé S (1997) Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. Eur Arch Psychiatry Clin Neurosci 247(3): 154-161. (Pubitemid 27257585)
48. Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Meltzer H (2001 a) Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation. Mol Psychiatry 6(4): 475-480. (Pubitemid 32566102)
49. Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpé S (2001b) Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol Med 31(5): 847-858. (Pubitemid 32621893)
50. Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpé S (2002) Depressive and anxiety symptoms in the early Puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci 71(16): 1837-1848 (Pubitemid 34880232)
51. Maes M, Mihaylova I, Ruyter MD, Kubera M, Bosmans E (2007) The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. Neuro Endocrinol Lett 28(6): 826-831.
52. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2010) The new 5-HT hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry accepted.
53. Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2011). Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS). Med Sci Monit. 17(4): SC11-5.
54. McRoberts JA, Coutinho SV, Marvizón JC, Grady EF, Tognetto M, Sengupta JN, Ennes HS, Chaban W, Amadesi S, Creminon C, Lanthorn T, Geppetti P, Bunnett NW, Mayer EA (2001) Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 120(7): 1737-1748. (Pubitemid 32523492)
55. Mecs L, Tuboly G, Nagy E, Benedek G, Horvath G (2009) The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model. Anesth Analg 109(4): 1297-1304.
56. Moir AT, Eccleston D (1968) The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J Neurochem 15(10): 1093-1108.
57. Moller SE (1985) Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments. Acta Psychiatr Scand Suppl 325: 3-31.
58. Morgan CJ, Badawy AA (1989) Effects of a suppression test dose of dexamethasone on tryptophan metabolism and disposition in the rat. Biol Psychiatry 25(3): 359-362. (Pubitemid 19044262)
59. Moroni F, Russi P, Gallo-Mezo MA, Moneti G, Pellicciari R (1991) Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. J Neurochem 57: 1630-1635. (Pubitemid 21922799)
60. Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B (2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98(1-2): 143-151. (Pubitemid 46048912)
61. Németh H, Toldi J, Vécsei L (2005) Role of kynurenines in the central and peripheral nervous systems. Curr Neurovasc Res 2(3): 249-260.
62. Oxenkrug GF (2007) Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann N Y Acad Sci 1122: 35-49.
63. Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15(4): 393-403.
64. Richell RA, Deakin JF, Anderson IM (2005) Effect of acute tryptophan depletion on the response to controllable and uncontrollable noise stress. Biol Psychiatry 57(3): 295-300. (Pubitemid 40187374)
65. Rief W, Fichter M (1992) The Symptom Check List SCL-90-R and its ability to discriminate between dysthymia, anxiety disorders, and anorexia nervosa. Psychopathology 25(3): 128-138.
66. Rief W, Hiller W, Heuser J (1997) SOMS - Das Screening für somatoforme Störungen. Manual zum Fragebogen. Bern: Huber.
67. Rief W, Hessel A, Braehler E (2001a) Somatization symptoms and hypochondriacal features in the general population. Psychosom Med 63(4): 595-602. (Pubitemid 32695140)
68. Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M (2001b) Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res 105(3): 165-174. (Pubitemid 34117644)
69. Rief W, Pilger F, IhIe D, Verkerk R, Scharpe S, Maes M (2004) Psychobiological aspects of somatoform disorders: contributions of monoaminergic transmitter systems. Neuropsychobiology 49(1): 24-29. (Pubitemid 38134864)
70. Rief W, Hennings A, Riemer S, Euteneuer F (2010) Psychobiological differences between depression and somatization. J Psychosom Res 68(5): 495-502.
71. Simon GE, VonKorff M (1991) Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study. Am J Psychiatry 148(11): 1494-1500.
72. Song C, Dinan T, Leonard BE (1994) Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 30(4): 283-288. (Pubitemid 24115279)
73. Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M (1998) The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 49(3): 211-219. (Pubitemid 28218842)
74. Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1(8): 609-620. (Pubitemid 37361524)
75. Struzik L, Duffin J, Vermani M, Hegadoren K, Katzman MA (2002) Effects of tryptophan depletion on central and peripheral chemoreflexes in man. Respir Physiol Neurobiol 133(3): 183-195. (Pubitemid 35300232)
76. Swardfager W, Herrmann N, Dowlati Y, Oh Pl, Kiss A, Walker SE, Lanctôt KL (2009) Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease. Psychoneuroendocrinology 34(10): 1560-1566.
77. Swartz M, Landerman R, George L, Blazer D, Escobar J (1990) Somatization disorder. In: Robins LN, Regier D, editors. Psychiatric Disorders in America. New York, Free Press.
78. Takikawa O, Yoshida R, Yasui H, Hayaishi O (1984) The relationship between plasma kynurenine and indoleamine 2,3-dioxygenase activity in the extrahepatic tissues. In: Schlossberger HG, Kochen W, Linzen B, Steinhart H, editors. Progress in Tryptophan and Serotonin Research. Berlin-New York: Walter de Gruyter and Co., pp 517-520.
79. Tanke MA, Alserda E, Doornbos B, van der Most PJ, Goeman K, Postema F, Korf J (2008) Low tryptophan diet increases stress-sensitivity, but does not affect habituation in rats. Neurochem Int 52(1-2): 272-281. (Pubitemid 350235702)
80. Terre L, Poston WS, Foreyt J, St Jeor ST (2003) Do somatic complaints predict subsequent symptoms of depression? Psychother Psychosom 72(5): 261-267.
81. van Veen JF, van Vliet IM, de Rijk RH, van Pelt J, Mertens B, Fekkes D, Zitman FG (2009) Tryptophan depletion affects the autonomic stress response in generalized social anxiety disorder. Psychoneuroendocrinology 34(10): 1590-1594.
82. Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M (2005a) Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychol Med 35(3): 433-41. (Pubitemid 40372481)
83. Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M (2005b) IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. MoI Psychiatry 10(6): 538-544. (Pubitemid 40897037)
84. Wittchen HU, Schramm E, Zaudig M, Unland H (1997) SKID: Stukturiertes klinisches Interview für DSM-IV, Achse I, deutsche Version. Göttingen: Hogrefe.
85. Wu LJ, Zhuo M (2009) Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain. Neurotherapeutics 6(4): 693-702.
86. Yang X, Yang HB, Xie QJ, Liu XH, Hu XD (2009) Peripheral inflammation increased the synaptic expression of NMDA receptors in spinal dorsal horn. Pain 144(1-2): 162-169.
87. Young SN (1981) Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis. Br J Pharmacol 74(3): 695-700.
88. Yuwiler A, Oldendorf WH, Geller E, Braun L (1977) Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J Neurochem 28(5): 1015-1023. (Pubitemid 8098869)
89. Zepf FD, Holtmann M, Stadler C, Wöckel L, Poustka F (2009) Reduced serotonergic functioning changes heart rate in ADHD. J Neural Transm 116(1): 105-108.